Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...
The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...
Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...
The 340B Drug Pricing Program (“340B Program”) space continues to be a hive of activity. While 340B stakeholders continue to litigate ongoing manufacturer contract pharmacy restrictions, states ...
The vast majority of hospitals that participate in the 340B drug pricing program do not follow recent hospital transparency regulations requiring them to report the prices they charge for oncology ...
The White House has proposed good and bad ideas to reduce drug costs. Among the better ones is a reform of the obscure 340B drug program, which enriches large hospitals at the expense of patients. Cue ...
The 100% woman-owned consulting firm partners with healthcare organizations to help them understand, implement, and optimize the federal government’s complex 340B Drug Discount Program. SARASOTA, FL / ...
AstraZeneca, a major pharmaceutical company, has sued Utah’s Attorney General Derek Brown over a recently passed state law allowing for lower pricing in pharmacies. The lawsuit concerns how SB69, ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback